Serial Achieva Limited Receives Approval-In-Principle for Listing and Quotation of Subscription Shares
Key Developments Investors Should Know
- Approval-In-Principle Granted: Serial Achieva Limited has received approval-in-principle from the Singapore Exchange for the listing and quotation of 21,004,873 new ordinary shares. These shares are to be issued to UFCT Technology Co., Limited as part of a previously announced subscription agreement.
- Conditional Listing: The listing is subject to Serial Achieva’s compliance with all relevant Exchange listing requirements. The approval-in-principle does not guarantee that the subscription or listing will actually be completed.
- Investor Caution: The Board of Serial Achieva advises shareholders and potential investors to exercise caution when dealing or trading in the company’s shares, as there is no certainty that the Proposed Subscription will be completed or that the terms will remain unchanged.
- Potential Price Sensitivity: The issuance of over 21 million new shares could significantly impact the company’s share capital structure and, consequently, its share price. Investors should be aware that changes in share issuance and dilution can have material effects on valuation.
- Professional Advice Recommended: The announcement urges investors to consult with professional advisers such as stockbrokers, bank managers, solicitors, accountants, or tax advisers if they are unsure about the actions to take in light of this development.
- Further Updates: Serial Achieva will make additional announcements if there are material updates or changes to the terms of the Proposed Subscription.
- Regulatory Notes: The announcement has been reviewed by the company’s sponsor, RHT Capital Pte. Ltd., but not by the Singapore Exchange Securities Trading Limited, which assumes no responsibility for its contents.
- Contact Information: Investors who have questions regarding this matter can contact Mr. Khong Choun Mun at RHT Capital Pte. Ltd., 36 Robinson Road, #10-06 City House, Singapore 068877, Email: [email protected].
Analysis & Implications for Shareholders
The approval-in-principle for the listing and quotation of the Subscription Shares marks a significant corporate event for Serial Achieva Limited. If completed, this transaction will result in the issuance of a substantial number of new shares, which may dilute existing shareholders’ interests and could potentially affect share prices due to changes in supply and valuation metrics.
However, it is crucial to note that this approval-in-principle is not an endorsement of the merits of the Proposed Subscription, and there remains uncertainty regarding its completion. Investors should closely monitor further announcements from the company and exercise caution in any trading decisions related to Serial Achieva Limited’s shares. The Board’s clear warning about the uncertainty of completion and possible changes to the terms underscores the importance of vigilance.
In summary, the news is potentially price-sensitive due to the large number of shares involved and the implications for the company’s capital structure. The outcome of this process could affect market sentiment and share valuation, so investors should be attentive to further disclosures and market developments.
Disclaimer
The information above is for general informational purposes only and does not constitute investment advice. Investors are advised to consult their own professional advisers before making any investment decisions. The Singapore Exchange Securities Trading Limited has not examined or approved the contents of this announcement and assumes no responsibility for its correctness.
赛瑞成就有限公司获得原则性批准以挂牌及报价认购股份
投资者应知的关键发展
- 原则性批准：赛瑞成就有限公司已获得新加坡交易所的原则性批准，将发行21,004,873股新普通股，认购方为UFCT Technology Co., Limited，作为此前公告的认购协议部分。
- 条件挂牌：挂牌需赛瑞成就有限公司遵守所有相关交易所挂牌要求。原则性批准并不保证认购或挂牌一定会完成。
- 投资者谨慎：董事会建议股东和潜在投资者在买卖公司股份时保持谨慎，因为认购未必一定完成，条款也可能变动。
- 潜在价格敏感：发行超过2,100万新股将显著影响公司股本结构，并可能影响股价。股东应注意，股份发行和稀释变化会对估值产生实质影响。
- 建议咨询专业人士：公告建议投资者如有疑虑，应咨询专业顾问，如股票经纪人、银行经理、律师、会计师或税务顾问。
- 后续公告：若认购有重大更新或条款变动，公司将发布进一步公告。
- 监管说明：公告已由公司赞助商RHT Capital Pte. Ltd.审核，但未获新加坡交易所审查或批准，新交所不对内容负责。
- 联系方式：如有疑问可联系RHT Capital Pte. Ltd.的Khong Choun Mun先生，地址：新加坡罗宾逊路36号10-06市府大厦，电邮：[email protected]。
股东分析与影响
获得认购股份挂牌及报价原则性批准，是赛瑞成就有限公司的重要公司事件。如若完成，将发行大量新股，可能稀释现有股东权益，并因供应及估值变化影响股价。
但必须注意，该批准并非对认购优点的认可，且完成仍有不确定性。投资者应密切关注公司后续公告，对相关交易保持警惕。董事会明确警告完成的不确定性和条款可能变动，强调警惕的重要性。
总结而言，该消息因涉及大量股份及对资本结构的影响，具有价格敏感性。认购过程结果可能影响市场情绪和股价，投资者应关注后续披露与市场动态。
免责声明
以上信息仅供参考，不构成投资建议。投资者应在做出任何投资决策前咨询自身专业顾问。新加坡交易所未审查或批准本公告内容，对其正确性不负责。
